Immunotherapy in Esophagogastric Adenocarcinoma

Stein, A; Thuss-Patience, P

Stein, A (reprint author), Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Tumorctr UCCH, Dept Internal Med 2, Oncol Ctr, Martinistr 52, DE-20246 Hamburg, Germany.

VISCERAL MEDICINE, 2019; 35 (1): 12

Abstract

Immunotherapy, particular PD-1/L1 inhibition, is a relevant treatment approach in esophagogastric adenocarcinoma. To date, single-agent activity is li......

Full Text Link